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Abstract
Methylphenidate is a psychostimulant widely used in the treatment of attention deficit hyperactivity
disorder (ADHD). Here we report a novel paradigm that affords inferences about habituation and
attention to a novel stimulus in a familiar environment in a single test session without prior training
of the animals. The paradigm was used to assess the effects of methylphenidate (2.5 and 5.0 mg/kg,
sc) in young adult, male, Long-Evans rats. Methylphenidate increased locomotor activity during the
initial exposure to the test apparatus in a non-dose-related manner. However, upon introduction of a
novel spatial stimulus (an alcove) in the familiar environment, methylphenidate-treatment resulted
in dose-related increases in distance traveled and inhibition of long dwell times in the alcove, the
latter behavior being characteristic of vehicle-treated rats’ response to the alcove condition. These
results demonstrate the utility of this paradigm in the elucidation of the behavioral effects of a drug
commonly used in the treatment of ADHD. Findings also suggest that species-typical response
preferences in rats (e.g., refuge-seeking) may emerge in experimental settings that add spatial novelty
to otherwise featureless test enclosures commonly used to assess locomotor activity.
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Methylphenidate, the most widely used drug in the treatment of attention deficit hyperactivity
disorder (ADHD), increases synaptic availability of dopamine by blocking reuptake; in
addition, the drug blocks the reuptake of norepinephrine (Kaplan et al., 1998). These effects
on brain monoamines appear to ameliorate some of the frontolimbic dysfunction believed to
underlie ADHD (Filipek et al., 1997; Lou et al., 1989; Zametkin et al., 1990), and thus improve
attention (e.g. time on task) and consequently decrease general activity (e.g., “fidgeting”) in
individuals with the disorder.
Although there are several well established tests of attentional function in rodents, such as the
sustained attention task (Brockel and Fowler, 1995; Skjoldager and Fowler, 1991), which is
analogous to the continuous performance task used in humans (Chee et al., 1989; Kornetsky,
1972), these tests require considerable training of the animals. Accordingly, there is a need for
methods that enable evaluation of drug treatments and other manipulations on attention-related
behaviors in a single test session without prior training, as well as tests that assess other aspects
of attention-related functioning. Based on the observation that individuals with ADHD exhibit
higher levels of activity in familiar environments than in novel environments (Sagvolden and
Sergeant, 1998; Sleator and Ullmann, 1981), we designed an exploration/habituation/spatial
change paradigm that affords inferences about habituation and attention to a novel stimulus in
a familiar environment in a single test session that does not require prior training of the animals.
In this report, we present the effects of methylphenidate on the behavior of normal young adult
rats in our paradigm, thereby demonstrating the utility of this paradigm to elucidate effects of
a drug used in the treatment of ADHD. The results also suggest that species-typical response
preferences in rats (in this case, “seeking refuge”) may emerge in experimental settings that
add spatial novelty to otherwise featureless test enclosures commonly used to assess locomotor
activity.
2. Materials and methods
All experiments were conducted in accordance with the NIH Guide for the Care and Use of
Laboratory Animals and were approved by the University of Kansas Medical Center Animal
Care and Use Committee.
2.1. Animals and husbandry
Young adult (postnatal day 70–72), male, Long-Evans rats (n = 13 per group; each from a
different litter) were bred in-house from breeding stock obtained from Harlan (Indianapolis,
IN) as part of a larger diet study. Rats were group-housed (3 per cage) in a temperature- and
humidity-controlled animal facility with a 12-h light/dark cycle (on at 06:00 h). Except during
the behavioral assessment sessions, rats had ad libitum access to chow (AIN-93G; Teklad,
Indianapolis, IN) and water. Rats were weighed regularly and were accustomed to handling
prior to the commencement of experiments.
2.2. Apparatus
Modified force-plate actometers (Fowler et al., 2001) were used to assess response to
environmental spatial change. The modified plexiglass actometer chamber consisted of a
“main” compartment (28 × 42 cm) and a small “alcove” (14 × 14 cm) separated from the main
compartment area by a removable guillotine-type door (Fig. 1). Spatial resolution of the
actometer was less than 2 mm and temporal resolution was 0.02 sec.
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All testing occurred between 10:00 h and 13:00 h and was conducted under dim, indirect
lighting conditions. Rats were transported to the testing room in their home cages 1 hr prior to
testing. Activity and response to spatial change in the environment were measured during a 3-
stage, 90-min session in the modified force-plate actometer chambers (Fig. 1). Rats were
injected with methylphenidate (2.5 or 5.0 mg/kg, sc in a volume of 1 ml/kg; Sigma-Aldrich,
St. Louis, MO) or saline vehicle (1 ml/kg) and returned to the home cage. These doses were
selected because they were reported to induce locomotion, but not stereotypies (Costall and
Naylor, 1975;Gupta et al., 1971;Marriott, 1968), findings which we confirmed in a pilot study
(data not shown). Fifteen min after injection, each rat was placed in the main compartment
(Period 1 - Habituation) with the door to the alcove closed. After 30 min, the rat was removed
from the main compartment, placed in the home cage for 10 min, and then returned to the
unchanged main compartment (Period 2 – Probe for spontaneous recovery) for 20 min. After
Period 2, the rat was again removed from the main compartment to the home cage for 10 min,
and then returned to the main compartment with the door to the alcove open (Period 3 - Novel
stimulus in familiar environment) for 20 min. Movement of the rat in the main compartment
and alcove was automatically quantified by the x–y coordinates and Fz forces derived from
the force plate. Analyzing the Fz data (total vertical force) at 50 samples/sec allowed for the
quantification of variation in force during all movements (i.e., both locomotor and non-
locomotor behaviors).
2.4. Data analysis
Data are generally presented as group means ± SEM. The dependent variables used to describe
behavior were distance traveled, number of low mobility bouts, number of alcove visits, alcove
visit durations, and the variation of the vertical or Fz forces during Period 3. An alcove visit
was defined as the center of force coordinates of the rats falling within the alcove spatial limits
for 0.5 sec or more, followed by center of force coordinates being located outside the alcove
space for 0.5 sec or more. Alcove visit duration was the time between the defined entry and
exit criteria. The data analysis depicted in Fig. 5 involved the calculation of a separate linear
regression coefficient for each of the 39 rats where cumulative alcove visit duration was the
dependent variable and elapsed time within Period 3 was the independent (“predictor”)
variable. The resulting slopes were subjected to a one-way ANOVA. Group means of these
slopes are plotted as the thick lines in Fig. 5. This approach weights each subject equally,
whereas a regression for all the aggregated data for the 13 rats in each group does not yield
equal weighting. For any of the analyses, when data exhibited evidence of substantially unequal
error variances, as is often the case for latency or response duration measures, the data values
were subject to log10 transformation before ANOVA procedures were performed. Data were
analyzed for statistically significant effects by a variety of ANOVA designs, Tukey’s HSD,
paired and non-paired t-tests using SYSTAT v.10.2 (Systat Software, Inc, Chicago, IL).
Significance was assumed at P<.05.
3. Results
The first part of this section reports the effects of behavioral manipulations and
methylphenidate treatment on distance traveled. The second part of the analysis focuses on
additional dependent variables that provide a detailed view of the behavioral responses induced
by alcove exposure and how methylphenidate influenced those responses to the novel spatial
stimulus.
3.1. Distance traveled
The effects of methylphenidate on distance traveled were assessed across the three observation
periods in 5-min time blocks (Fig. 2). During Period 1 (initial habituation), there was a
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significant main effect of methylphenidate treatment (F2,36=47.761, P<.01), with the 2.5 and
5.0 mg/kg doses of methylphenidate producing similar increases in distance traveled compared
to saline (P<.01 for both comparisons); however, the effects of 2.5 and 5.0 mg/kg dose were
not statistically different from each other during Period 1. Distance traveled declined
significantly across 5-min time blocks, (F5,180=82.812, P<.01), with all groups exhibiting
initial high levels of exploratory activity during the first time block and gradually decreasing
activity across the next 5 time blocks. In this initial period, there was no interaction between
dose and time block.
Although a variety of drugs that increase extracellular striatal dopamine (amphetamine,
cocaine, methylphenidate, etc.) can induce a focused stereotypy syndrome that suppresses
locomotion, analysis of low-mobility bouts (1 bout is a rat staying within a 4 cm diameter circle
for 10 sec continuously) suggested that focused stereotypy did not contribute to the similarity
in the effects of the 2.5 and 5.0 mg/kg doses of methylphenidate on distance traveled during
Period 1. The number of low-mobility bouts was statistically indistinguishable for these two
groups (group means ± SEM were 16.23 ± 2.61 and 16.69 ± 4.65 for 2.5 mg/kg and 5.0 mg/
kg groups, respectively). Furthermore, the numbers of low-mobility bouts in both
methylphenidate groups were substantially and significantly (P<.01) fewer than the number of
low-mobility bouts observed in the vehicle-control group (99.00 ± 7.36) in which low mobility
arose from habituation processes and not from drug treatment. Thus, these observations are
not consistent with induction of stereotypy at either methylphenidate dose. Accordingly, the
possibility of focused stereotypy playing role in the data beyond Period 1 was not further
entertained because drug elimination would make the emergence of locomotion-inhibiting
focused stereotypy even less probable in Periods 2 and 3 than in Period 1.
To demonstrate that within-period habituation (Leussis and Bolivar, 2006) had occurred as
expected for the vehicle-control group, a post hoc paired t-test compared time blocks 1 and 6
in Period 1 (data points labeled a and b in Fig. 2). Confirming this expectation, examination
of individual subject data showed that all vehicle-control rats exhibited lower distance traveled
at point b than at point a (t12=7.544, P<.01). A decrease in distance traveled across time blocks
was also observed for both methylphenidate-treated groups, despite stimulation of locomotor
activity by the drug. The difference in initial activity between groups, expressed as the percent
decrease in distance traveled between time blocks 1 and 6 in Period 1, indicated that the 5 mg/
kg group exhibited less habituation than controls (−35% and −73%, respectively, P<0.01).
During Period 2, there was a significant main effect of methylphenidate dose on distance
traveled (F2,36=37.633, P<.01). The decline in distance traveled across time blocks was shallow
but significant (F3,108=4.077, P<.01), but time block and dose did not interact significantly.
Both methylphenidate groups exhibited significantly more activity than the vehicle group (P<.
01 for both comparisons); however, unlike Period 1, the difference between the 2.5 and 5.0
mg/kg groups was significant (P<.05). In addition, re-placement of the rats into the test chamber
for Period 2 after a 10-min period in the home cage, resulted in greater locomotor activity in
vehicle control rats during the first time block of Period 2 (point c in Fig. 2) compared to the
habituated behavior observed for the last time block of Period 1 (point b in Fig. 2) (t12=1.994,
P<.05, one tailed directional hypothesis). This comparison was not significant for either of the
two methylphenidate dose groups indicating that the drug-related hyperlocomotion interfered
with the expression of spontaneous recovery.
During Period 3, when the alcove was available, distance traveled was defined on the basis of
movements outside the alcove, as was the case for distance traveled in Periods 1 and 2.
Movements inside the alcove were characterized by an analysis of visits to the alcove and
variation in force movement as described below (3.2). Given the alcove’s relatively small size
(14 cm × 14 cm) and the high resolution of the recording instrument, it was thought that distance
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traveled inside the alcove would not be a suitable metric for measuring behavior inside the
alcove. This choice did not preclude an examination of the effect of alcove availability on
distance traveled outside the alcove. The main effect of methylphenidate dose on distance
traveled outside the alcove remained significant, (F2,36=31.741, P<.01) in Period 3. The time
block effect within Period 3 was also significant (F3,108=29.996, P<.01). However, unlike the
case in Periods 1 and 2, the interaction between dose group and time block was significant,
(F6,108=3.464, P<.01). Furthermore, the difference in distance traveled outside the alcove
between the 2.5 and 5.0 mg/kg groups remained significant (P<.01) and was more pronounced
than in Period 2. In addition, in the vehicle group, introduction of the novel spatial stimulus
appears to have induced re-exploration of the now familiar main compartment as evidenced
by the fact that habituation between Period 2 and Period 3 did not occur [i.e., data point d,
which shows the distance traveled only in the main compartment floor area, would be expected
to be lower than point c if between-period habituation had occurred, but this was not the case
(P>.10 by paired t-test, directional hypothesis)].
Tracings of movement trajectories within the actometer across the three periods are shown in
Fig. 3 for one representative rat from each of the three methylphenidate dose groups. These
patterns of movement are in accord with the statistical analyses based on distance traveled.
However, these tracings of the rats’ use of space show that the distance traveled measure, as a
behavioral descriptor, neglects important information about a rats’ response to
methylphenidate. For example, Fig. 3 shows that the vehicle rat spent the entire 4th 5-min time
block of Period 3 inside the alcove, while the two methylphenidate rats shared time between
the alcove and the space outside the alcove during the corresponding time block.
3.2. Alcove derived measures of behavior
3.2.1. Number and duration of alcove visits—Data in Fig. 4 (Panel A) show that the
number of alcove visits was significantly higher for methylphenidate-treated rats than for the
vehicle controls (F2,36=12.000, P<.01); however, post hoc analysis did not detect any
difference between the two doses of methylphenidate. Panel B in Fig. 4 shows that the
methylphenidate-treated rats displayed mean visit durations that were significantly shorter than
those of the controls (F2,36=7.521, P<.01). Again, post hoc comparisons for visit duration did
not detect a reliable difference between the two dose groups.
3.2.2. Visit duration as a function of time—The data presented so far suggest that
vehicle-treated rats spent more time in the alcove than in the main compartment compared to
methylphenidate-treated rats, but these data are not directly informative on the patterning of
visits across Period 3. To elucidate how visit durations changed as a function of the passage
of time in Period 3, we plotted cumulative alcove visit durations as a function of elapsed time
in Period 3 (Fig. 5, gray points and gray lines connecting the points for each rat). This is
analogous to an operant response cumulative record, except that the y-axis is not cumulative
number of visits. Instead the ordinate is cumulative visit duration. For each rat, a linear
regression was performed to compute the slope of the linear relation between accumulating
alcove dwell time and elapsed time within Period 3. The steeper the slope, the higher the rate
of accumulation of time in the alcove. Plots of the records for each subject give an indication
of the number of visits (each data point marks the end of an alcove visit). The regression
coefficients (13 coefficients for each dose group) were subjected to a one-way AVONA, which
indicated a significant drug treatment effect, F(2,36)=14.193, P<.01. Post hoc analyses showed
that the methylphenidate groups had slopes significantly lower than the control group (P<.01,
both comparisons), but the two drug groups were not significantly different from each other.
Therefore, with this analysis we were able to show that alcove occupancy grew much faster
with time for the vehicle group than for the drug groups
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3.2.3. Latency to enter the alcove and early visit durations—Although the analysis
represented in Fig. 5 showed that alcove visit time grew much faster for rats in the vehicle
group compared to the methylphenidate group, it does not provide detail about the first few
visits. Accordingly, this subset of the data was examined with additional analyses. By one-way
ANOVA, latency to enter the alcove during the initial time block of Period 3 did not differ
significantly among the three groups. The group means for the control, 2.5 mg/kg, and 5.0 mg/
kg groups were (in s) 5.1 (±1.5), 11.2 (±3.0), and 13.7 (±4.0), respectively. Discovery of the
alcove was approximately equally quick by the 3 groups (but with a trend for methylphenidate
to delay entry into the alcove). Fig. 6 provides group averages for the first seven alcove visits
in Period 3. Seven was chosen because it was a practical limit beyond which there was a large
amount of missing data for the vehicle group which overall had a mean number of seven visits
(see Fig. 4, panel A). A two-way repeated measures ANOVA (with group means imputed for
a total of 5 cells in the vehicle group for the 6th and 7th visits) indicated significant drug
treatment, ordinal position, and interaction effects with test statistics of F(2, 36)=10.449, P<.
01; F(6, 211)= 4.712, P<.01; and F(6,211)=2.665, P<.01, respectively. Post hoc analysis (t-
test, vehicle versus the two drug groups combined) showed that the vehicle group first
significantly diverged from the methylphenidate groups by the 5th visit. (t37=2.802, P<.01).
Thus, the beginning of the 5th alcove visit can be seen as the time in Period 3 when the vehicle-
treated rats began to show a significant preference for occupying the alcove over the main
compartment; the geometric mean (i.e., antilog of the mean Log10 times) marking the beginning
of the 5th visit was 198.2 s (±42.0). Taken together, these analyses of the early alcove visits
suggest that on the average there were no significant methylphenidate effects until after the
4th visit, and this was about the time that the vehicle rats began to express long-duration visits.
3.2.4. Force variability in the alcove—With the force-plate method of measuring a
specimen’s location (x–y coordinate at each instant), the force information and the position
information are independent mathematically. This is why the same force plate actometer can
be used to track the movements of a rat or a mouse (Fowler et al., 2001). Analysis of the force
data provides information about reactive force production during movement. Such force
measures can be used to operationalize concepts such as strength or relaxation of movements
even if the specimen is “staying in one place”. Accordingly, the standard deviation of force
variation in Period 3 was used as a dependent variable to examine further the impact on behavior
of the alcove and methylphenidate manipulations. For data collected while rats were inside the
alcove (Fig. 7, Panel A), ANOVA detected significant effects of methylphenidate dose
(F2,36=21.234, P<.01), time block (F3,108=17.137, P<.01), and an interaction of time block-
by-treatment (F6,108=5.497, P<.01). Outside the alcove (Fig. 7, Panel B), the methylphenidate
dose effect was significant (F2,36=15.599, P<.01), as was the time block effect (F3,108=12.720,
P<.01). However, the interaction effect was not significant. Post hoc analyses did not detect
differences between the 2.5 and 5.0 mg/kg doses either inside or outside the alcove. Post hoc
analyses further indicated that the SD of Fz was significantly higher for both drug groups than
the vehicle-control group both inside and outside the alcove. These data showed that
methylphenidate treatment led to higher reactive force levels than those exhibited by the
vehicle-control group and that reactive forces can be used to chart the course of habituation to
a novel environmental event when levels of locomotion are already relatively low. The sample
raw force data presented in Fig. 8 are generally in accord with the analyses based on the group
data.
4. Discussion
The novel behavioral paradigm described here enables the assessment of exploratory behavior,
habituation, and response to a spatial change in a familiar environment in a single test session
and requires no prior training of the animals. The behavioral changes occurring during
habituation of the exploratory response represents an elementary form of behavioral plasticity
Fowler et al. Page 6













involving learning, memory, arousal level, and attention (Berlyne, 1969; Leussis and Bolivar,
2006), processes highly relevant for assessing the effects of psychoactive drugs, particularly
psychostimulants. In addition, the test enables assessment of within-period habituation, which
involves 1) learning in the form of gaining familiarity with a novel environment; 2) adaptation
in the form of between-period habituation, which involves memory of the prior period (Leussis
and Bolivar, 2006); and 3) response to spatial change.
Methylphenidate increases synaptic availability of dopamine and norepinephrine by blocking
reuptake (Kaplan et al., 1998). In rats, methylphenidate has a proportionately larger effect on
increasing extracellular norepinephrine in the dorsal hippocampus compared to the elevation
of extracellular dopamine produced in the nucleus accumbens (Kuczenski and Segal, 2001,
2002). In agreement with previous studies in rodents (Costall and Naylor, 1975; Gupta et al.,
1971; Marriott, 1968), the present findings indicate that, at the doses tested, methylphenidate
increased locomotion, but did not induce stereotypy. Overall, the effects of methylphenidate
were more dose-related later, compared to earlier, in the in the 90-min assessment procedure.
In addition, methylphenidate significantly increased the amplitude of reactive force variation
during movements.
Although the force-plate technology records the force variations that accompany grooming
and wall rearing, two behaviors often targeted in locomotor activity studies of CNS stimulants
(e.g., Wooters and Bardo, 2009), quantifying these specific behaviors was not attempted in this
project. Nevertheless, by looking at relevant literature, it may be informative to consider
whether or not the methylphenidate-related results for the SD of Fz data may have been
influenced by grooming and rearing. In the dose range used here, it is unlikely that the observed
methylphenidate-related increase in force variability (Fig. 7) was a reflection of increases in
either grooming or wall rearing. After a single methylphenidate dose of 5.6 mg/kg, sc., Wooters
and Bardo (2009) reported an insignificant increase in rears and a non-significant decrease in
amount of grooming (data derived from video-taped observations on male Sprague-Dawley
rats from the same supplier we used). Preliminary data from our laboratory (Fowler et al.,
2009) showed that 2.5 mg/kg d-amphetamine sulfate significantly increased amplitude of force
changes during runs covering 45 cm in 1.5 s in a 0.8 × 0.8 m force-plate actometer. Given that
both amphetamine and methylphenidate block norepinephrine transporters as well as dopamine
transporters, and given that norepinephrine increases spinal motoneuron excitability (White et
al., 1991), we suggest that, in part, the methylphenidate-elevated force variability shown in
Fig. 7 was a result of the drug’s induction of greater locomotion than that seen in controls
combined with more forceful limb movements during locomotion. The increased force
variation during locomotion induced by methylphenidate may also partly be the result of
increased brain dopamine since increased force production has been shown to be associated
with activation of dopamine-rich brain loci (e.g., ventral striatum; Schmidt et al., 2009). The
foregoing points plus the relatively low rates of methylphenidate-related occurrence of
grooming [about 1.4 instances in 3 min (Wooters and Bardo, 2009)] and rearing [7.0 instances
in 3 min (Wooters and Bardo, 2009)], along with brief durations of these behaviors in the
undrugged state [grooming: 4–6 s/episode (Aldridge and Berridge, 1998); wall rearing: 1–5s/
rear (unpublished observations)], suggest that these behaviors did not substantially contribute
to the methylphenidate-induced elevation of SD of Fz (Fig. 7). Instead, the amount and intensity
of locomotion probably underlie methylphenidate’s effect on SD of Fz in this setting.
Even though overall activity level was higher in the methylphenidate-treated rats, within-period
habituation to the novel test chamber environment (Period 1) occurred in both control and
methylphenidate-treated rats as indicated by the parallel activity curves across Period 1 time
blocks; However, methylphenidate-treated rats habituated less than controls relative to initial
activity. The decreased within-period habituation with methylphenidate was similar to that
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reported in apomorphine-treated rats (Carlsson, 1972) and likely reflects the increased
stimulation of D1-like and D2-like dopamine receptors produced by both drugs.
The introduction of spatial change in the environment (i.e., the novel alcove stimulus) in Period
3 produced the greatest differences between the methylphenidate-treated and vehicle-control
rats, and also showed the greatest dose-related effects of methylphenidate. In controls, the
introduction of the novel alcove in Period 3 led to initially increased locomotor activity and
progressively increasing alcove occupancy times. Accordingly, for vehicle-control rats, the
introduction of the novel stimulus of the alcove was a “preferred” space as indicated by their
long dwell times there compared to the main compartment of the chamber that they had already
explored. Preferential exploration of novel stimuli by normal control rats has also been reported
in a number of studies using various paradigms such as introduction of a novel object, etc.
(e.g., Buhot and Naili, 1995; Dai and Carey, 1994; Oitzl et al., 1994). Furthermore, in our
paradigm, exposure of the control group to the alcove prompted re-exploration of the outer,
main compartment of the chamber.
Methylphenidate altered the rats’ responses to the presence of the alcove. In the initial time
block of Period 3, both methylphenidate dose groups exhibited a small decrease in outside-
the-alcove distance traveled compared to the last time block of Period 2 (see Fig. 2). In contrast,
the vehicle group exhibited a significant increase in outside-the-alcove distance traveled for
the same time blocks (block 12 versus block 15). These results differ from previous reports
that the locomotor effects of cocaine or amphetamine, psychostimulants with mechanisms of
action similar to methylphenidate’s, were potentiated in a “completely” novel environment
compared to a familiar one (Carey and Damianopoulos, 1996;Kyatkin, 1992;Uslaner et al.,
2001); however, these earlier studies compared exposures to drugs in novel environments
relative to the home cage, and thus possibly assessed different processes than those produced
by the introduction of the open alcove in the test apparatus used here. Methylphenidate did not
significantly impair rats’ latency to enter the alcove for the first time, nor did the drug
differentially affect the duration of the first few visits compared to the vehicle control condition.
However, after about 3 min in Period 3, the methylphenidate-treated rats made many more
alcove visits that were of shorter duration than those exhibited by the rats that received vehicle
injections. When in the alcove, methylphenidate-treated rats moved more and more forcefully
than controls. These data show that methylphenidate did not impair initial sampling of or
attention to the alcove space, but the drug markedly interfered with the expression of quiet
resting and lack of locomotion that was characteristic of the rats in the control group.
The relatively quick adoption of the alcove by the vehicle-control rats suggests that the alcove
may have provided a species-relevant stimulus of biological importance. Work by several
investigators (e.g., Townsend, 1997; Whishaw et al., 2006) has shown that “shelters” or
“refuges” placed within the boundaries of larger “open fields” are readily occupied by rats.
The smaller enclosures within the larger spaces had dimensions similar to those of the alcove
used here; thus, each space (“shelter”, “refuge”, alcove) was small enough to allow the rat to
cutaneously and/or vibrissally sense multiple walls concurrently. Townsend (1997) interpreted
the rats’ preference for shelters in terms of anxiety reduction, whereas Whishaw et al. (2006)
suggested that occupancy of a small enclosed space (“refuge”) located within a larger space (a
soccer field!) reflected a rat’s innate tendency to seek spaces that optimize bodily security (e.g.,
to increase probability of avoidance of, or escape from, predators). This work with shelters
provides a plausible explanation for the fact that the alcove produced a spatial preference and
a rapid exploration/habituation response to the alcove in the vehicle-control rats. Although,
this interpretation makes sense for the vehicle-control group, it is difficult to reconcile this idea
with the disruptive effect of methylphenidate treatment on alcove behavior; that is,
methylphenidate treatment interfered with the normal expression of the adaptive preference
for a shelter or refuge in an open field. It has been suggested that amphetamine and cocaine,
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drugs with brain/behavioral effects similar to methylphenidate, increase fear and anxiety in
rats (e.g., Blanchard and Blanchard, 1999; Markham et al., 2006). If optimization of security
and reduction of fear/anxiety are reflexively intertwined processes in a rat (i.e., the evocation
of shelter seeking is also accompanied by fear and anxiety), then methylphenidate treatment
would be expected to increase, not decrease, alcove occupancy because drug-induced increased
fear/anxiety would make the alcove (“shelter”, “refuge”) a more preferred location than it
would be in the non-drugged state. An alternative interpretation of the disruptive effect of
methylphenidate on alcove behavior in Period 3 is that methylphenidate induced (reflexively-
elicited) compulsive locomotion or inability to stay in one place for more than 10 to 20 sec.
The locomotion of methylphenidate-treated rats can be aptly described as “reflexively-evoked”
because (1) the locomotion overrode the expression of a biologically important response and
(2) the locomotion bouts and alcove visits were relatively constant across the 20 min of Period
3 (e.g., data for the 5.0 mg/kg dose in Fig. 5). While these interpretations may appear
contradictory to the therapeutic effects of methylphenidate in ADHD patients, the drug appears
to produce “paradoxical” effects in ADHD patients as suggested by the report that dopamine
transporter function appears to be altered in ADHD patients (Mazei-Robison et al., 2008); thus,
the effects in normal rats or humans may differ from effects in individuals with ADHD.
Furthermore, laboratory assay procedures for describing the behavioral effects of drugs in
animals need not have face validity in order to have predictive validity for a particular disorder
(Geyer and Markou, 1995).
In conclusion, the present findings demonstrate the utility of this behavioral paradigm for
assessing exploratory activity, within-period habituation, and response to a spatial modification
of a test environment in a single test session and without prior training. More specifically, the
effects of methylphenidate on alcove-related behavior highlights the complex interplay among
novelty, habituation, and drug-elicited behaviors in rats. These findings also indicate that
species-typical response preferences in rats, such as refuge-seeking, may be discerned in test
paradigms that introduce spatial novelty to otherwise featureless test enclosures commonly
used to assess locomotor activity. In the future, it will be interesting to determine the effects
of other psychostimulants and other classes of psychoactive drugs in this paradigm and to
further assess the biological relevance of the “refuge-like” properties of the alcove.
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Fig 1. Schematics of the experimental apparatus (top) and test protocol (bottom)
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Fig. 2. Dose-response effects of methylphenidate on distance traveled outside the alcove as a
function of 5-min time blocks within Periods 1, 2, and 3
In Periods 1 and 2 only space outside the alcove was available for occupancy by the rats. Data
are presented as the group means ± SEM (n =13 per group). When error bars are not visible,
the size of the plot symbol was greater than 2 SEM. Lower case alphabetic characters (a, b, c,
d) represent specific means for 5-min blocks that were compared for the control group (0.0
mg/kg).
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Fig. 3. Movement trajectories of individual rats shown in 5-min blocks within each of three
successive periods
Representative movement trajectories are presented for three different rats from each of the
treatment groups. Numbers 1 through 6 along the left side of the figure represent successive
5-min time blocks. Note that the back 1/3 of the chamber was inaccessible in Periods 1 and 2
(see Fig. 1). Inaccessible regions can be discerned by noting that no tracings are present in
those regions (back third of the chamber in Periods 1 and 2, and left and right back corners in
Period 3).
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Fig. 4. Number of alcove visits (Panel A) and mean alcove visit duration (Panel B) for Period 3 as
a function of methylphenidate dose
Data are presented as the group means ± SEM (n = 13 per group). ** P<.01 vs. vehicle control
by Tukey’s post hoc test.
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Fig. 5. Cumulative alcove occupancy duration as a function of elapsed time in Period 3 for vehicle
control and methylphenidate dose groups
Gray symbols and gray connecting lines show individual rat data. Each individual data point
marks the end of a visit or the presence of the rat in the alcove when Period 3 ended. The thick
black lines indicate mean lines of best fit reflecting the rate of accumulation of alcove
occupancy time during Period 3. The slope for the vehicle group was significantly (P<.01)
steeper than the slopes for the two methylphenidate groups. In the plot for vehicle rats, the
arrow indicates a rat that was not in the alcove when Period 3 ended, but instead was
continuously located a few mm outside the alcove (as determined by inspection of its movement
trajectory plot). On the x-axis, the scale markers 300, 600, 900, and 1200 s correspond to the
successive 5-min blocks 15, 16, 17, and 18, respectively, of Period 3 in Fig. 2.
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Fig. 6. Group average alcove visit duration as a function of ordinal position of visits in Period 3
Note that the log10 scale value of 1.0 on the ordinate indicates 10 s and 2.0 represents 100 s.
Data are presented as group means ± SEM. ** P<.01 vs. vehicle control by Tukey’s post hoc
test.
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Fig. 7. Variation in vertical force as a function of 5-min block and location within the force plate
actometer during Period 3
Data are presented as group means ± SEM (n = 13 per group). “SD” in the ordinate label is an
abbreviation for “standard deviation.” Sample raw data for Fz time series are shown in Fig. 8.
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Fig. 8. Representative time series of vertical force variation of Fz over the first 15 s of the 4th time
block of Period 3
Data are from the same three rats whose data are shown in Fig. 3. Force data from the load
plate were collected at 50 samples/sec. Inside (event line “up”) and outside (event line “down”)
refer to spatial categories in the actometer (inside or outside of the alcove) where the rat was
located when these data were gathered. Raw data such as these served as the basis for the
quantitative assessment of force output depicted in Fig. 7
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